User Name Password

back to homepage

Columbia Yukon Explorations (CYU.V) - encouraging assay and metallurgical results

Comment by Objective Capital , Sep 26, 2008
Click for previous reports on this company
Questions? Contact our analyst

Columbia Yukon Explorations obtained encouraging assay and metallurgical results from its Storie molybdenum project in northern British Columbia. The results continue to demonstrate the company’s potential to economically exploit the Storie deposit.

Assays from the latest five holes all indicated substantial molybdenum intervals. Intervals ranged from 144 metres to 294 metres, with molybdenum grades ranging from 0.057 percent to 0.081 percent. These results are especially encouraging, as all five holes are beyond the limits of the previously defined deposit.

Columbia Yukon retained SGS Mineral Services to investigate options for molybdenum recovery from the Storie ore. Initial results are promising. SGS concluded that saleable concentrate can be produced through a simple and traditional process, using proven methods. Further, no significant processing problems are anticipated. The final concentrate graded at 54 percent molybdenum, with a 69-percent molybdenum recovery, with “locked cycle” recoveries as high as 87 percent. SGS is now processing a larger sample, which should significantly improve locked cycle recoveries.

Objective's view:

The latest assays suggest the company may be able to substantially increase its mineral resource estimate. Further, indications continue to point to the presence of a higher-grade zone running through the deposit. The initial SGS testing suggests there will be no unpleasant metallurgical surprises and concentrate grades and recoveries will be in line with our estimates. We view the latest results as encouraging and supportive of our base-case and optimistic valuations of Columbia Yukon.

SIGN UP NOW FOR OBJECTIVE'S STOCK RESEARCH - IT'S FREE!

Objective, Independent, Experienced.
Research you can trust!

Yes! Subscribe me for the latest stock research from Objective.
Email address
My Password
My information:
First Name
Family Name
Title:
Job title:
Job function:
Industry:
I am a:
 
To receive occasional printed reports complete your mailing address:
 
Company Name (if any)
Address
 
 
City
Postcode/Zip
Country

Please Read Objective's Terms of Use.


Balkan Resources (Private) - exploring the Perlati copper deposit in Albania
Oct 09, 2009 | Previous Reports

Scancell Holdings (SCLP.PLUS) - differentiated technology and a focused plan offer ingredients for success
Sep 08, 2009 | Previous Reports

Sofame Technologies (SDW.V) - ambitious, but high risk growth strategy
Aug 24, 2009 | Previous Reports

Soho Resources (SOH.V) - substantial upgrade to total resource
Aug 19, 2009 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

e-Therapeutics (ETX.L) - ‘success-predictive’ drug discovery may be the key to new treatment horizons
Nov 18, 2008 | Previous Reports

Great Western Minerals (GWG.V) - pressing ahead with mine-to-market strategy
Nov 07, 2008 | Previous Reports

LiDCO (LID.L) - half year results show early signs of being on track
Oct 30, 2008 | Previous Reports

OCCASIONAL PAPERS

Albania - revisting old frontiers
October, 2008

The rise of independent research (IR Magazine)
March, 2006

Presentation to 2005 AIM Conference
Sept 26, 2005

The Role of Sponsored Research
June 22, 2005

Objective's Corporate Brochure
July 01, 2004

Objective Capital's Contact Information
Partnership, sales and product inquiries: marketing@objectivecapital.co.uk
Media services and conference requests: PR@objectivecapital.co.uk
Subscription and customer service issues: service@objectivecapital.co.uk
Comments or opinions on our analysis: analysis@objectivecapital.co.uk

11-12 Tokenhouse Yard, London EC2R 7AS, United Kingdom
ph +44-(0)870-080 2965 fax +44-(0)870-116 0839

About Us | Contact Us
Latest Analysis | Register Free | Archives
 
Copyright 2004 Objective Capital. All rights reserved.
Terms of Use | Privacy Policy | Disclaimer